22. EQUITY-BASED COMPENSATION

 

The following table summarizes the amounts the Company recognized as equity-based compensation expense including restricted stock, restricted units, membership units of consolidated sponsor entities and stock options. These amounts are included as a component of compensation and benefits in the consolidated statements of operations. The remaining unrecognized compensation expense related to unvested awards at December 31, 2025 was $5,895 and the weighted average period of time over which this expense will be recognized is approximately 1.6 years. 

  

 

 

 

 

EQUITY-BASED COMPENSATION INCLUDED IN COMPENSATION AND BENEFITS

(Dollars in Thousands)

 

  

For the Year Ended December 31,

 
  

2025

  

2024

  

2023

 

Equity-based compensation expense

 $20,213  $4,668  $4,391 

Non equity-based compensation expense

  157,305   51,720   47,701 

Total compensation and benefits

 $177,518  $56,388  $52,092 

 

The following table summarizes the equity-based compensation by plan.  Each plan is discussed in detail below.

 

DETAIL OF EQUITY-BASED COMPENSATION BY PLAN

(Dollars in Thousands)

 

  

For the Year Ended December 31,

 
  

2025

  

2024

  

2023

 

Restricted Stock or Units - 2020 Plan

 $4,542  $4,668  $4,391 

Membership interests in sponsor entities

  15,671   -   - 

Total equity-based compensation expense

 $20,213  $4,668  $4,391 

 

The Company’s 2020 Long-Term Incentive Plan – Restricted Common Stock, Restricted Units, and Stock Options

 

On April 7, 2020, the board of directors of the Company adopted a long-term incentive plan (the “2020 Long Term Incentive Plan”), which was approved by the Company’s stockholders at the Company’s annual meeting on June 18, 2020. On April 1, 2021 and June 9, 2021, the board of directors and the Company stockholders, respectively, approved Amendment No. 1 to the 2020 Long-Term Incentive Plan, which increased the maximum number of shares of common stock available for issuance under the 2020 Long-Term Incentive Plan from 600,000 shares of common stock to 1,200,000 shares of common stock. On  March 28, 2022 and June 2, 2022, the board of directors and the Company stockholders, respectively, approved Amendment No. 2, which increased the maximum number of shares of common stock available for issuance under the 2020 Long-Term Incentive Plan, as amended, from 1,200,000 shares of common stock to 1,900,000 shares of common stock.  On March 28, 2025 and June 4, 2025, the board of directors and the Company stockholders, respectively, approved Amendment No. 3 to the 2020 Long-Term Incentive Plan, which increased the maximum number of shares of common stock available for issuance under the 2020 Long-Term Incentive Plan from 1,900,000 shares of common stock to 2,500,000 shares of common stock. As of  December 31, 2025, 818,002 shares remain available to be issued under the Company's 2020 Long-term Incentive Plan. No award may be granted under the 2020 Long Term Incentive Plan after April 7, 2030.

 

The Company's 2010 Long- Term-Incentive Plan and the AFN 2006 Equity Plan expired in 2020 and there are no shares available to be issued under these plans.

 

Membership Interests of Consolidated Sponsor Entities

 

Employees sometimes invest in the membership interests of consolidated SPAC sponsor entities.  Because these entities are consolidated and the employees are investing in the consolidated company's non-controlling interest, these equity interests fall under FASB ASC 718.  Generally, the employee invests a de minimis amount and receives an allocation of the founder shares held by the sponsor entity.  The investment generally does not have any explicit vesting criteria associated with it.  Generally, the employee's investment will be worthless if the SPAC in which the sponsor entity has invested is liquidated and it will become worth something if the SPAC completes its business combination.  Therefore, the Company treats these grants as having a performance condition (i.e. the completion of the SPAC business combination).  Further, at the time of the investments, the Company treats this performance condition as being non-probable.  The effect of this is that the Company records no expense related to these investments until (and only if) the business combination is completed.  Upon completion of the business combination, the Company records compensation expense in an amount equal to the fair value of the grant.  The fair value of the grant is equal to the public trading price of the SPAC on the grant date adjusted for certain sale restrictions imposed on the shares the employee receives (generally, the shares are restricted for sale for some time period and subject to certain hurdle prices before they become freely tradeable).  

 

RESTRICTED STOCK - SERVICE BASED VESTING

 

  

Number of Shares of Restricted Stock

  

Weighted Average Grant Date Fair Value

 

Unvested at January 1, 2023

  341,059  $16.17 

Granted

  143,900   7.57 

Vested

  (113,301)  17.18 

Forfeiture

  (4,167)  11.65 

Unvested at December 31, 2023

  367,491   12.54 

Granted

  153,125   8.91 

Vested

  (114,491)  13.97 

Forfeiture

  (1,334)  8.81 

Unvested at December 31, 2024

  404,791   10.79 

Granted

  144,200   14.23 

Vested

  (149,981)  12.70 

Forfeiture

  (19,002)  8.82 

Unvested at December 31, 2025

  380,008  $11.44 

 

 

 

  

 

OPERATING LLC RESTRICTED UNITS - SERVICE BASED VESTING

 

  

Number of Restricted Units

  

Weighted Average Grant Date Fair Value

 

Unvested at January 1, 2023

  6,541,490  $1.35 

Granted

  422,000   0.68 

Vested

  (1,438,160)  1.97 

December 31, 2023

  5,525,330   1.82 

Granted

  422,000   1.02 

Vested

  (1,481,332)  1.87 

Unvested at December 31, 2024

  4,465,998   1.73 

Granted

  422,000   1.68 

Vested

  (1,621,996)  1.77 

Unvested at December 31, 2025

  3,266,002  $1.71 

 

During the years ended December 31, 2025, 2024, and 2023, the total fair value of all equity awards vested in each year based on the fair market value of the Common Stock on the vesting date was $3,105, $1,940, and $2,249, respectively.

 

The restricted shares and restricted units typically may vest quarterly, annually, or at the end of a specified term on a straight-line basis over the remaining term of the awards, assuming the recipient is continuing in service to the Company at such date, and, in the case of performance-based equity awards, the performance thresholds have been attained. In the case of director grants, the equity awards have no performance or service conditions.  In the cases of graded vesting, the Company typically expenses the grant on a straight-line basis if only service conditions are present but expenses on a graded basis if performance-based conditions are present. Upon vesting, restricted shares and units are entitled to receive any distributions or dividends that were declared subsequent to the grant date and up to the date of vesting.  Any restricted shares or units that do not vest do not receive distributions or dividends.  The Company accrues for these dividends and distributions on unvested shares and units when the dividends or distributions are declared.  This liability is included as a component of accounts payable and other liabilities in the consolidated balance sheet.  When restricted shares or units are forfeited, any accrued dividends and distributions that were accrued are reversed.  

 

SPONSOR ENTITY MEMBERSHIP UNITS - PERFORMANCE BASED VESTING

 

  

Membership Units

  

Weighted Average Grant Date Fair Value

 

Unvested at January 1, 2023

  -  $- 

Granted

  -   - 

Vested

  -   - 

Forfeited

  -   - 

Unvested at December 31, 2023

  -   - 

Granted

  -   - 

Vested

  -   - 

Forfeited

  -   - 

Unvested at December 31, 2024

  -   - 

Granted

  4,190,000   3.74 

Vested

  (4,190,000)  3.74 

Forfeited

  -   - 

Unvested at December 31, 2025

  -  $- 

   

During the years ended December 31, 2025, 2024, and 2023, the total fair value of all equity awards vested in each year based on the fair market value of the membership units on the vesting date was $15,671, $0, and $0, respectively.

 

Historical Timeline

Fiscal YearFiled
2025Mar 6, 2026Showing above
2024Mar 12, 2025

About Stock Compensation Disclosures

Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.

Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.